Literature DB >> 22841988

Modelling normal and impaired letter recognition: implications for understanding pure alexic reading.

Ya-Ning Chang1, Steve Furber2, Stephen Welbourne3.   

Abstract

Letter recognition is the foundation of the human reading system. Despite this, it tends to receive little attention in computational modelling of single word reading. Here we present a model that can be trained to recognise letters in various spatial transformations. When presented with degraded stimuli the model makes letter confusion errors that correlate with human confusability data. Analyses of the internal representations of the model suggest that a small set of learned visual feature detectors support the recognition of both upper case and lower case letters in various fonts and transformations. We postulated that a damaged version of the model might be expected to act in a similar manner to patients suffering from pure alexia. Summed error score generated from the model was found to be a very good predictor of the reading times of pure alexic patients, outperforming simple word length, and accounting for 47% of the variance. These findings are consistent with a hypothesis suggesting that impaired visual processing is a key to understanding the strong word-length effects found in pure alexic patients.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22841988      PMCID: PMC3657697          DOI: 10.1016/j.neuropsychologia.2012.07.031

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  2 in total

1.  Lexical is as lexical does: computational approaches to lexical representation.

Authors:  Anna M Woollams
Journal:  Lang Cogn Neurosci       Date:  2015-04-21       Impact factor: 2.331

2.  What lies beneath: a comparison of reading aloud in pure alexia and semantic dementia.

Authors:  Anna M Woollams; Paul Hoffman; Daniel J Roberts; Matthew A Lambon Ralph; Karalyn E Patterson
Journal:  Cogn Neuropsychol       Date:  2014-04-07       Impact factor: 2.468

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.